Eight years ago, the Tokyo University of Science Researcher Network was founded as a forum for TUS researchers to communicate and interact through their research across the frame of departments and specialties. The network’s founding was preceded by multidisciplinary discussions between volunteers working toward the Global COE Program application. The aims of the network were not only to expand the research horizons of individual researchers, but also to discover and create interdisciplinary and new research fields through the understanding of other scientific disciplines. Then, in collaboration with National Cancer Center East Hospital, the Center for Technologies against Cancer (CTC) was founded in 2009 by researchers, including many of the network members. The aim of the center was to develop innovative diagnostic and treatment methods for cancer. Tokyo University of Science does not have a school of medicine, so the founding of the CTC was our first organizational effort to enter the fields of healthcare and medicine. Yet, we were able to make great strides and accomplish much. Notable achievements include hosting a total of 21 lectures by physicians at the National Cancer Center to advance the understanding of cancer treatment among our faculty members and students, and conducting on-campus recruitment of engineering and science faculty members to expand the Researcher Network and get them involved in healthcare or medical research for the first time. Upon the closing of the CTC in 2013, we decided to established the new research division to inherit, maintain, and expand what we have achieved from the CTC activities, such as the cooperative on- and off-campus networks connecting the fields of medicine, science, and technology. Through this division, we will continue ongoing research and development to promote the commercialization of research results, and will prepare for the founding of a new research center that will take over the cooperative projects developed by the CTC.
Director Ryo Abe: Professor,
Research Institute for Biomedical Science
With a life expectancy of 86 years for women and 80 years for men, Japan has become the world’s leading country in terms of longevity. However, to realize a society with sustainable health and longevity, it is essential to shift from hospital-based care to home healthcare, to prevent bed confinement and dementia, and to develop early diagnostic and treatment methods for chronic diseases such as cancer, cardiovascular and cerebral nerve diseases, allergic diseases, and autoimmune diseases. In collaboration with off-campus medical institutions, this research division integrates cross-sectionally the highly specialized science and technology developed at TUS with the aim of realizing innovative healthcare techniques that contribute to creating a society where people live long, healthy lives.